Comparative Risk of Adverse Treatment Effects in Parkinson'S Disease: Evidence from A Large Employer Population

Keith L. Davis; Juliana Leah Meyers; Keith L. Davis; TP Fitzgerald; A Kulkarni; Juliana Leah Meyers; P Svarvar; DJ Hewitt

Comparative Risk of Adverse Treatment Effects in Parkinson'S Disease

Evidence from A Large Employer Population

Davis, K., Fitzgerald, TP., Kulkarni, A., Meyers, J., Svarvar, P., & Hewitt, DJ. (2013). Comparative Risk of Adverse Treatment Effects in Parkinson'S Disease: Evidence from A Large Employer Population. Value in Health, 16(3), A100-A100.

Copy citation

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis

December 31, 2023

Article

Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach

December 01, 2023

Article

Consensus-based framework for evaluating data modernization initiatives

October 01, 2023

Article

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

September 15, 2023

View All Publications